The oncology information system market contains software & services designed for the complete management of information &
medical imaging, streamlining the handling of cancer patient data & treatments.
Within medical facilities like clinics, hospitals, & labs, electronic medical records (EHRs) are utilized to maintain patient profiles, plan treatments, anticipate outcomes, &share patient data among healthcare providers. These advancements improve the safety & effectiveness of cancer care, supporting doctors & surgeons in making enhanced treatment choices to improve cancer patients' chances of survival.
OIS Market Growth The Global Oncology Information System (OIS) Market is experiencing tremendous expansion due to the rising prevalence of cancer and demand for advanced cancer care solutions. Healthcare providers are adopting OIS in order to streamline patient data management, enhance treatment planning and improve communication between oncology teams for improved patient outcomes.
Recent advances in AI-powered analytics, cloud platforms and real-time data integration are revolutionizing oncology information systems (OIS). These developments allow healthcare professionals to make data-driven decisions and personalize treatment plans more accurately, improving both precision and efficiency during cancer treatments. Integration between OISs and electronic health records (EHRs) further encourages its widespread use.
As healthcare systems move towards digitization and interoperability, opportunities in the OIS market are expanding as healthcare systems put more effort into digitization and interoperability. Telemedicine solutions and remote patient monitoring applications continue to experience growth allowing vendors of OIS technologies to enhance their offerings and take advantage of expanding telemedicine demand.
With countries increasingly investing in healthcare infrastructure improvements and cancer care initiatives OIS technologies will only continue to develop offering further growth potential while improving overall patient experiences.
Notable conferences for Oncology Information System (OIS) solutions in 2018 included the American Society for Radiation Oncology (ASTRO) Annual Meeting and European Society for Medical Oncology (ESMO) Congress, both held each year to highlight advances in oncology, cancer care technologies and OIS solutions.
Market Dynamic
The rising global incidence of
cancer is a major factor contributing to the expansion of the oncology information system (OIS) market. According to GLOBOCAN 2020, there were more than 19 million new cancer cases reported worldwide in 2020, & is projected to increase by 47% to over 28 million by 2040.
The total number of cancer patients over the last five years, known as cancer prevalence, is expected to be over 50 million, with the growing prevalence of cancer highlighting the need for OIS to effectively manage patient information & data, thereby expanding the demand for oncology information systems.
However, the lack of qualified personnel proficient in utilizing these systems & software has the potential to hinder the growth of the global oncology information systems market over the forecast period, which further could impede the effective adoption & usage of OIS in healthcare settings.
Research Scope and Analysis
By Product
The global oncology information system market, based on products is categorized into two segments, which are solutions & professional services. As of 2023, the solutions segment holds the largest share of global revenue & is expected to exhibit the most rapid growth during the forecast period, which is driven by the growth in the adoption of solutions by healthcare providers to efficiently manage radiology imaging.
These solutions play a major role in capturing patient-reported outcomes from cancer patients & facilitating direct communication between patients & doctors, thus contributing to the segment's growth. Further, the development of more advanced OIS solutions that improve patient data management & improve cancer treatment also fuels this growth.
In addition, professional services are gaining traction, mainly because many hospitals & clinics are outsourcing OIS services due to a shortage of skilled professionals. These services provide online consultations, customized schedules, & reports, which ultimately enhance the quality of patient care.
By Application
The global market for oncology services is categorized into radiation oncology, medical oncology, & surgical oncology applications. In 2023, the largest share of global revenue is taken by the medical oncology segment, which is also projected to experience the fastest growth during the forecast period, mainly due to major advancements in hormonal therapy, immunotherapy, & targeted therapy, providing more effective solutions for treating several cancers. In addition, major players are actively involved in cancer research initiatives, further boosting the market's growth.
In addition, the surgical oncology segment is also expected to substantial growth in the coming years, as cancer care has evolved, & surgery alone is no longer the main treatment for most solid malignancies. Instead, a combination of surgery with other treatment modalities like targeted molecular therapies, radiotherapy, & chemotherapy is preferred.
Complex surgical procedures, like cytoreductive surgery, isolated limb perfusion, laparoscopic cancer surgery, & sarcoma surgery, are being performed in specialized
healthcare centers, with higher complexity in surgical cancer treatments expected to drive the market's growth.
By End User
The hospital sector holds the largest market share & plays a pivotal role in driving the growth of the Oncology Information System (OIS) market in 2023, which is expected to persist throughout the forecast period. Hospitals play an important role in providing comprehensive cancer care, including diagnosis, treatment, surgery, radiation therapy, & supportive care.
Further, they need robust OIS to efficiently manage the complex workflows & multidisciplinary care required for cancer patients. The hospital segment's growth is further fueled by larger patient populations, growth in collaboration among different medical disciplines, & the accreditation requirements set by hospitals as end-users.
Further, during the forecast period, specialty centers are anticipated to be the most profitable segment in the market. Given the difficulties of cancer treatment, specialized treatment techniques, & the emphasis on multidisciplinary teamwork & research, specialty centers have specific requirements that necessitate dedicated OIS.
These systems provide the essential tools, functions, & data management capabilities to meet the distinctive needs of specialty centers, ultimately helping them achieve optimal outcomes in cancer care delivery.
The Oncology Information System Market Report is segmented on the basis of the following:
By Product
- Solutions
- Professional Services
By Application
- Medical Oncology
- Surgical Oncology
- Radiation Oncology
By End User
- Hospitals
- Research Centers
- Specialty Clinics
Regional Analysis
In 2023, the North American region dominates the Oncology Information System (OIS) market, contributing
a major 39.4% of the total revenue, as the region's advanced healthcare infrastructure & a growing awareness of the importance of managing patient information efficiently.
In addition, the growth in the adoption of OIS to monitor cancer patient treatment outcomes & the rise in the significance of Electronic Medical Records (EMR) for making enhanced treatment decisions are driving the market in the region. Further, the need for OIS is also boosted by the growing demand for managing treatment schedules, doses, & treatment planning. Further, the presence of many major global players supports market growth in North America.
Also, the Asia Pacific region is expected to experience the fastest growth in the OIS market, as the region is increasingly recognizing the importance of OIS, driven by supportive government policies & growing awareness of the benefits of these systems, which presents significant opportunities for companies seeking to tap into this potential market.
To succeed in this region, businesses must customize their pricing & marketing strategies to cater to the unique needs of Asian markets, allowing them to establish a strong presence & capture a bigger share in these promising markets.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
Major companies are putting a lot of effort into making enhanced cancer treatment systems. They are working on utilizing new technology like web-based tools &
artificial intelligence to enhance how cancer is treated. These innovations look to make cancer care better & are likely to help the market grow in the coming years, which means that in the future, cancer patients might have access to more advanced and effective treatments owing to these high-tech solutions.
In May 2022, GE Healthcare announced its partnership with RaySearch Laboratories AB, a company that designs software for radiation therapy, to develop a fresh approach for planning &simulating radiation therapy for cancer treatment, which focuses on developing a more straightforward & efficient method for precisely directing radiation to shrink tumors. By working together, they intend to enhance the way radiation treatment is planned & carried out, ultimately benefiting patients by making cancer therapy more effective & easier to manage.
Some of the prominent players in the global Oncology Information System Market are:
- CureMD Corp
- Elekta AB
- Optum Inc
- EndoSoft LLC
- Brainlab
- Accuracy Inc
- Cerner Corp
- GE Healthcare
- MIM Software
- Philips Healthcare
- Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Oncology Information System Market
The COVID-19 pandemic had a significant impact on the global Oncology Information System (OIS) market. As healthcare systems around the globe switched their focus to controlling the pandemic, resources for cancer care & OIS implementation were redirected. Halt in cancer diagnoses & treatments occurred, affecting OIS adoption.
In addition, the economic recession resulted in financial constraints for healthcare providers, potentially lowering their investments in OIS. However, the pandemic also showcased the importance of digital health solutions like OIS for remote patient management & data analysis, which may drive market growth in the long term as the healthcare sector adapts to the new normal. Overall, the OIS market saw challenges during the pandemic, but it remains a critical component of modern oncology care.
Report Details
| Report Characteristics |
| Market Size (2023) |
USD 2.8 Bn |
| Forecast Value (2032) |
USD 5.7 Bn |
| CAGR (2023-2032) |
8.2% |
| Historical Data |
2017 - 2022 |
| Forecast Data |
2023 - 2032 |
| Base Year |
2022 |
| Estimate Year |
2023 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Product (Solutions and Professional Services), By
Application (Medical Oncology, Surgical Oncology,
and Radiation Oncology), By End User (Hospitals,
Research Centers, and Specialty Clinics) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
CureMD Corp, Elekta AB, Optum Inc, EndoSoft LLC,
Brainlab, Accuracy Inc, Cerner Corp, GE Healthcare,
MIM Software, Philips Healthcare, and Other Key
Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |